Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Crossref
1. TACE Plus Lenvatinib Versus TACE Plus Sorafenib for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Prospective Cohort Study
- Biao Yang
- Luo Jie
- Ting Yang
- Mingyang Chen
- Yuemei Gao
- Tian Zhang
- Yuzu Zhang
- Hao Wu
- Zhengyin Liao
2. Health-related quality of life in primary hepatic cancer: a systematic review assessing the methodological properties of instruments and a meta-analysis comparing treatment strategies
- Kerstin Wohlleber
- Patrick Heger
- Pascal Probst
- Christoph Engel
- Markus K. Diener
- André L. Mihaljevic
3. Hepatocellular Carcinoma is an Emerging Issue Now in Iran
- Seyed Moayed Alavian
4. Advances in the Ablative Management of Hepatocellular Carcinoma
- Beau B. Toskich
- Ryan E. Bailey
- Sadeer J. Alzubaidi
- Zlatko Devcic
- Gregory T. Frey
- Andrew R. Lewis
- Michael R. Moynagh
- Kabir Mody
- Charles A. Ritchie
- Terence T. Sio
- Tushar Patel
- Ricardo Paz-Fumagalli
6. Value of quality of life analysis in liver cancer: A clinician’s perspective
- Leung Li
- Winnie Yeo
7. Contemporary Systematic Review of Health-Related Quality of Life Outcomes in Locoregional Therapies for Hepatocellular Carcinoma
- Arighno Das
- Ahmed Gabr
- Daniel P. O’Brian
- Ahsun Riaz
- Kush Desai
- Bartley Thornburg
- Joseph R. Kallini
- Samdeep Mouli
- Robert J. Lewandowski
- Riad Salem
8. Ruptured Hepatocellular Carcinoma: What Do Interventional Radiologists Need to Know?
- Jingxin Yan
- Ting Li
- Manjun Deng
- Haining Fan